HiLo-Trial: 30% vs 60% Oxygen at Birth in Very Low Birthweight Infants

Phase 3, randomised trial of oxygen gas in preterm birth (2 arms), sponsored by University College Cork. Primary endpoint: Composite of all-cause mortality or major neurodevelopmental impairment at 18–24 months corrected age. Planned start May 2024; status: authorised.